| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 77.514 | 96.297 | 100.585 | 105.204 | 99.358 | 96.147 | 96.442 | 109.018 | 112.660 | 120.216 |
| Total Income - EUR | 77.519 | 96.303 | 100.585 | 105.204 | 99.354 | 96.149 | 96.443 | 109.019 | 117.478 | 119.117 |
| Total Expenses - EUR | 66.921 | 81.298 | 96.907 | 82.201 | 80.389 | 94.748 | 92.896 | 108.022 | 109.171 | 110.590 |
| Gross Profit/Loss - EUR | 10.598 | 15.004 | 3.678 | 23.004 | 18.965 | 1.400 | 3.547 | 996 | 8.307 | 8.527 |
| Net Profit/Loss - EUR | 8.474 | 14.041 | 2.672 | 21.951 | 17.971 | 439 | 2.583 | -39 | 7.132 | 2.977 |
| Employees | 0 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
Check the financial reports for the company - Andimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 30.904 | 19.797 | 9.422 | 5.118 | 5.314 | 6.516 | 5.496 | 93.145 | 67.270 | 46.603 |
| Current Assets | 68.266 | 82.433 | 76.233 | 64.602 | 53.460 | 10.414 | 12.544 | 14.900 | 11.722 | 28.087 |
| Inventories | 148 | 0 | 0 | 0 | 0 | 33 | 33 | 0 | 984 | 0 |
| Receivables | 15.507 | 18.236 | 11.189 | 10.289 | 1.648 | 2.253 | 1.405 | 1.688 | 7.307 | 19.192 |
| Cash | 52.610 | 64.197 | 65.045 | 54.314 | 51.812 | 8.127 | 11.106 | 13.212 | 3.431 | 8.895 |
| Shareholders Funds | 79.821 | 93.048 | 70.289 | 59.448 | 50.058 | 7.783 | 10.193 | 10.185 | 17.286 | 3.025 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 19.349 | 9.182 | 15.672 | 10.967 | 8.743 | 9.220 | 7.993 | 97.931 | 61.706 | 71.664 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Andimed Srl